High rate of fecal carriage of extended-spectrum-β-lactamase-producing Escherichia coli in healthy children in Gipuzkoa, northern Spain

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 3, 2014, Pages 1822-1824

  Fernández Reyes, María ^a   Vicente, Diego ^a,b   Gomariz, María ^a   Esnal, Olatz ^b   Landa, Joseba ^a,c   Oñate, Eider ^a   Pérez Trallero, Emilio ^a,b,c  

^a HOSPITAL DONOSTIA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZTREONAM; BETA LACTAM; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; LACTAM; LEVOFLOXACIN; NALIDIXIC ACID; TICARCILLIN;

ACUTE DIARRHEA; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CHILD; CROSS INFECTION; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FECES MICROFLORA; FEMALE; HUMAN; INFANT; MALE; NORMAL HUMAN; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SPAIN;

BETA-LACTAM RESISTANCE; CARRIER STATE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; HUMANS; INFANT; PREVALENCE; RISK FACTORS; SPAIN;

EID: 84896838458     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01503-13     Document Type: Article

References (21)

1. Pitout JD, Laupland KB. 2008. Extended-spectrum β-lactamase- producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159-166. http://dx.doi.org/10.1016/S1473-3099(08)70041-0. (Pubitemid 351249250)
2. Coque TM, Baquero F, Canton R. 2008. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill. 13:pii=19051. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19044.
3. Clinical and Laboratory Standards Institute. 2011. Performance standard for antimicrobial susceptibility testing; 20th informational supplement, M100-S21, vol 31, no 1. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Fang H, Ataker F, Hedin G, Dornbusch K. 2008. Molecular epidemiology of extended-spectrum β-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006. J. Clin. Microbiol. 46:707-712. http://dx.doi.org/10.1128/JCM.01943-07. (Pubitemid 351231321)
5. Schmitt J, Jacobs E, Schmidt H. 2007. Molecular characterization of extended-spectrum beta-lactamases in Enterobacteriaceae from patients of two hospitals in Saxony, Germany. J. Med. Microbiol. 56(Part 2):241-249. http://dx.doi.org/10.1099/jmm.0.46670-0.
6. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558. http://dx.doi.org/10.1128/AEM.66.10.4555-4558.2000.
7. Jauréguy F, Carbonnelle E, Bonacorsi S, Clec'h C, Casassus P, Bingen E, Picard B, Nassif X, Lortholary O. 2007. Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis. Clin. Microbiol. Infect. 13:854-862. http://dx.doi.org/10.1111/j.1469-0691.2007.01775. x. (Pubitemid 47244134)
8. Clermont O, Bonacorsi S, Bingen E. 2007. CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 59:165-174.
9. European Antimicrobial Resistance Surveillance Network (EARS-Net). 2013. Proportion of 3rd generation cephalosporins resistant (R+I) Escherichia coli isolates in participating countries. EARS-Net, Stockholm, Sweden. http://ecdc.europa.eu/en/activities/surveillance/EARS-Net/database/Pages/ graph-report.aspx?MasterPage=1.
10. Valverde A, Coque TM, Sánchez-Moreno MP, Rollán A, Baquero F, Cantón R. 2004. Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J. Clin. Microb. 42:4769-4775. http://dx.doi.org/10.1128/ JCM.42.10.4769-4775.2004. (Pubitemid 39362401)
11. Vinué L, Sáenz Y, Martínez S, Somalo S, Moreno MA, Torres C, Zarazaga M. 2009. Prevalence and diversity of extended-spectrum beta-lactamases in fecal Escherichia coli isolates from healthy humans in Spain. Clin. Microbiol. Infect. 15:954-957. http://dx.doi.org/10.1111/j.1469-0691. 2009.02803.x.
12. Rodríguez-Baño J, López-Cerero L, Navarro MD, Díaz de Alba P, Pascual A. 2008. Faecal carriage of extended-spectrum beta-lactamaseproducing Escherichia coli: prevalence, risk factors and molecular epidemiology. J. Antimicrob. Chemother. 62:1142-1149. http://dx.doi.org/10. 1093/jac/dkn293.
13. Valverde A, Grill F, Coque TM, Pintado V, Baquero F, Cantón R, Cobo J. 2008. High rate of intestinal colonization with extended-spectrum- lactamase-producing organisms in household contacts of infected community patients. J. Clin. Microbiol. 46:2796-2799. http://dx.doi.org/10.1128/JCM.01008- 08.
14. Guimarães B, Barreto A, Radhouani H, Figueiredo N, Gaspar E, Rodrigues J, Torres C, Igrejas G, Poeta P. 2009. Genetic detection of extended-spectrum beta-lactamase-containing Escherichia coli isolates and vancomycin-resistant enterococci in fecal samples of healthy children. Microb. Drug Resist. 15:211-216. http://dx.doi.org/10.1089/mdr.2009.0910.
15. Birgy A, Cohen R, Levy C, Bidet P, Courroux C, Benani M, Thollot F, Bingen E. 2012. Community fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in French children. BMC Infect. Dis. 12:315. http://dx.doi.org/10.1186/1471-2334-12-315.
16. Kaarme J, Molin Y, Olsen B, Melhus A. 2013. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in healthy Swedish preschool children. Acta Paediatr. 102:655-660. http://dx.doi.org/10.1111/apa. 12206.
17. Boutet-Dubois A, Pantel A, Prère MF, Bellon O, Brieu-Roche N, Lecaillon E, Le Coustumier A, Davin-Regli A, Villeneuve L, Bouziges N, Gleize E, Lamarca R, Dunyach-Remy C, Sotto A, Lavigne JP. 2013. Faecal carriage of oxyiminocephalosporin-resistant Enterobacteriaceae among paediatric units in different hospitals in the south of France. Eur. J. Clin. Microbiol. Infect. Dis. 32:1063-1068. http://dx.doi.org/10.1007/s10096-013-1851-7.
18. Ojer-Usoz E, González D, Vitas AI, Leiva J, García- Jalón I, Febles-Casquero A, Escolano Mde L. 2013. Prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae in meat products sold in Navarre, Spain. Meat Sci. 93:316-321. http://dx.doi.org/10.1016/j. meatsci.2012.09.009.
19. Briñas L, Moreno MA, Zarazaga M, Porrero C, Sáenz Y, García M, Dominguez L, Torres C. 2003. Detection of CMY-2, CTX-M-14, and SHV-12 β-lactamases in Escherichia coli fecal-sample isolates from healthy chickens. Antimicrob. Agents Chemother. 47:2056-2058. http://dx.doi.org/10.1128/ AAC.47.6.2056-2058.2003. (Pubitemid 36637846)
20. Torres C, Zarazaga M. 2007. BLEE en animales y su importancia en la transmisión a humanos. Enferm. Infecc. Microbiol. Clin. 25(Suppl 2):29-37.
21. Foxman B. 2013. Editorial commentary: extended-spectrum β-lactamase-producing Escherichia coli in the United States: time to rethink empirical treatment for suspected E. coli infections? Clin. Infect. Dis. 56:649-651. http://dx.doi.org/10.1093/cid/cis947.